PROPANC BIOPHARMA, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | 366.8% | 690.5% | -2,482.0% |
| FY2017 | 144.6% | 401.0% | -8,275.6% |
| FY2018 | 104.3% | 342.9% | -9,860.6% |
| FY2019 | 133.9% | 217.8% | -5,664.8% |
| FY2020 | 130.2% | 227.5% | -4,812.0% |
| FY2021 | 66.0% | 82.9% | -15,464.1% |
| FY2022 | 87.9% | 126.7% | -3,255.4% |
| FY2023 | 85.4% | 97.6% | -4,410.2% |
| FY2024 | 48.2% | 53.9% | -2,515.8% |
| FY2025 | -423.7% | -407.9% | -300.1% |